Skip to content

13F-HR filed by Darwin Global Management, Ltd.

Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 12 holding rows worth $543,280,000.

Accession
0001420506-21-001717
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 12 entries on the cover page, a total value of $543,280,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $543,280,000 with VALUE read as thousands by filing date, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACCELERON PHARMA INC00434H108COM2,000,000$344,200,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM752,024$100,884,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR132,932$36,289,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM353,250$20,937,000thousands by filing date
INHIBRX INC45720L107COM542,586$18,074,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM253,692$11,891,000thousands by filing date
INVIVYD INC00534A102COMMON STOCK86,528$3,655,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock159,393$2,869,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM45,311$1,972,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM27,397$1,288,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK33,997$959,000thousands by filing date
AEROVATE THERAPEUTICS INC008064107COM12,484$262,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-001717this filing2021-11-15acceptance time not in the bulk data set